BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 19364827)

  • 1. Pharmacokinetic study of enclosed hemoglobin and outer lipid component after the administration of hemoglobin vesicles as an artificial oxygen carrier.
    Taguchi K; Urata Y; Anraku M; Maruyama T; Watanabe H; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Kai T; Otagiri M
    Drug Metab Dispos; 2009 Jul; 37(7):1456-63. PubMed ID: 19364827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatically-metabolized and -excreted artificial oxygen carrier, hemoglobin vesicles, can be safely used under conditions of hepatic impairment.
    Taguchi K; Miyasato M; Ujihira H; Watanabe H; Kadowaki D; Sakai H; Tsuchida E; Horinouchi H; Kobayashi K; Maruyama T; Otagiri M
    Toxicol Appl Pharmacol; 2010 Nov; 248(3):234-41. PubMed ID: 20709091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute.
    Sou K; Klipper R; Goins B; Tsuchida E; Phillips WT
    J Pharmacol Exp Ther; 2005 Feb; 312(2):702-9. PubMed ID: 15459236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice.
    Taguchi K; Urata Y; Anraku M; Watanabe H; Kadowaki D; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Maruyama T; Otagiri M
    Drug Metab Dispos; 2009 Nov; 37(11):2197-203. PubMed ID: 19679674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated injection of high doses of hemoglobin-encapsulated liposomes (hemoglobin vesicles) induces accelerated blood clearance in a hemorrhagic shock rat model.
    Taguchi K; Iwao Y; Watanabe H; Kadowaki D; Sakai H; Kobayashi K; Horinouchi H; Maruyama T; Otagiri M
    Drug Metab Dispos; 2011 Mar; 39(3):484-9. PubMed ID: 21123166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model.
    Sakai H; Horinouchi H; Masada Y; Takeoka S; Ikeda E; Takaori M; Kobayashi K; Tsuchida E
    Biomaterials; 2004 Aug; 25(18):4317-25. PubMed ID: 15046922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of single and repeated injection of hemoglobin-vesicles in hemorrhagic shock rat model.
    Taguchi K; Maruyama T; Iwao Y; Sakai H; Kobayashi K; Horinouchi H; Tsuchida E; Kai T; Otagiri M
    J Control Release; 2009 Jun; 136(3):232-9. PubMed ID: 19245823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days.
    Sakai H; Masada Y; Horinouchi H; Ikeda E; Sou K; Takeoka S; Suematsu M; Takaori M; Kobayashi K; Tsuchida E
    J Pharmacol Exp Ther; 2004 Dec; 311(3):874-84. PubMed ID: 15297471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: profiles of hemoglobin-vesicle degradation and hematopoiesis for 14 days.
    Sakai H; Seishi Y; Obata Y; Takeoka S; Horinouichi H; Tsuchida E; Kobayashi K
    Shock; 2009 Feb; 31(2):192-200. PubMed ID: 18520699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in reticuloendothelial system.
    Sakai H; Horinouchi H; Tomiyama K; Ikeda E; Takeoka S; Kobayashi K; Tsuchida E
    Am J Pathol; 2001 Sep; 159(3):1079-88. PubMed ID: 11549600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hemoglobin vesicles, a liposomal artificial oxygen carrier, on hematological responses, complement and anaphylactic reactions in rats.
    Abe H; Azuma H; Yamaguchi M; Fujihara M; Ikeda H; Sakai H; Takeoka S; Tsuchida E
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(2):157-72. PubMed ID: 17453702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year observation of Wistar rats after intravenous infusion of hemoglobin-vesicles (artificial oxygen carriers).
    Sakai H; Tsuchida E; Horinouchi H; Kobayashi K
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):81-91. PubMed ID: 17364473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ability of polyethylene glycol conjugated bovine hemoglobin (PEG-Hb) to adequately deliver oxygen in both exchange transfusion and top-loaded rat models.
    Conover CD; Linberg R; Shum KL; Shorr RG
    Artif Cells Blood Substit Immobil Biotechnol; 1999 Mar; 27(2):93-107. PubMed ID: 10092932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoglobin vesicles and red blood cells as carriers of carbon monoxide prior to oxygen for resuscitation after hemorrhagic shock in a rat model.
    Sakai H; Horinouchi H; Tsuchida E; Kobayashi K
    Shock; 2009 May; 31(5):507-14. PubMed ID: 18827742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity, and blood flow during 90% exchange transfusion in anesthetized rats.
    Sakai H; Takeoka S; Park SI; Kose T; Nishide H; Izumi Y; Yoshizu A; Kobayashi K; Tsuchida E
    Bioconjug Chem; 1997; 8(1):23-30. PubMed ID: 9026031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of hemoglobin vesicles during cardiopulmonary bypass priming prevents neurocognitive decline in rats.
    Yamazaki M; Aeba R; Yozu R; Kobayashi K
    Circulation; 2006 Jul; 114(1 Suppl):I220-5. PubMed ID: 16820576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome-encapsulated actin-hemoglobin (LEAcHb) artificial blood substitutes.
    Li S; Nickels J; Palmer AF
    Biomaterials; 2005 Jun; 26(17):3759-69. PubMed ID: 15621266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performances of PEG-modified hemoglobin-vesicles as artificial oxygen carriers in microcirculation.
    Sakai H; Tsuchida E
    Clin Hemorheol Microcirc; 2006; 34(1-2):335-40. PubMed ID: 16543654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Static structures and dynamics of hemoglobin vesicle (HBV) developed as a transfusion alternative.
    Sato T; Sakai H; Sou K; Medebach M; Glatter O; Tsuchida E
    J Phys Chem B; 2009 Jun; 113(24):8418-28. PubMed ID: 19469497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoglobin-vesicles as an artificial oxygen carrier.
    Sakai H; Sou K; Tsuchida E
    Methods Enzymol; 2009; 465():363-84. PubMed ID: 19913177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.